Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A high-profile concentration in AMZN is drawing attention to what Pershing Square Capital Management sees as durable strength inside Amazon’s business, according to a recent report.
THE APEX TIMES
THE APEX TIMES
Moderna shares surged roughly 11% in a move reported as occurring with no accompanying company news, while BioNTech’s performance lagged the moment’s momentum. Traders are now asking whether the market is moving toward a single favored mRNA name, or simply repricing near-term risk across the platform.
THE APEX TIMES
A market analysis argues that NVIDIA’s current valuation reflects expectations that the market may already be pricing in ahead of time, and that the effective multiple investors pay can look smaller once a longer time horizon is applied.
THE APEX TIMES
A reported burst of activity in Kalshi’s Nvidia Compute Markets has raised fresh questions about whether investors will treat GPU time like an investable input, not just an output of chipmakers.
THE APEX TIMES
Oracle shares have fallen sharply over the past year, but one investor featured in a market commentary says the selling misses what he sees as an imbalance in valuation revealed in the company’s own reporting.
THE APEX TIMES
Nvidia chief executive Jensen Huang urged investors in Seoul to take advantage of weakness, arguing that the market’s pullback created an opportunity. Traders are now watching whether that timing view holds up as the stock rebounds moderately.
THE APEX TIMES
In Q2 2026, both Eli Lilly and Novo Nordisk stayed at the center of the weight-loss drug race, but their latest moves diverged sharply: one company raised guidance while the other announced layoffs, pipeline write-downs, and a major price cut.
THE APEX TIMES
The reported transaction adds to the ongoing attention on how Berkshire Hathaway builds positions in big-cap technology names, while raising questions about the structure of the deal and timing.
THE APEX TIMES
Traders bid up Meta Platforms after a market report tied the stock move to expectations for a new AI agent and a forthcoming October model, highlighting how quickly investors are repricing the company’s artificial-intelligence roadmap.
